Financials • Major Banks
$23.66 ▲ +0.45
(+1.94%)
MKT CAP: $11.21B • VOL: 7.19M
52W L $20 52W H $27
FHN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.42B | $3.19B | $3.47B |
| YoY Revenue Growth % | +7.2% | -8.0% | — |
| Gross Profit | $1.50B | $1.40B | $1.53B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.16B | $914.5M | $1.06B |
| Operating Margin % | 33.9% | 28.7% | 30.5% |
| Net Income (GAAP) | $982.0M | $775.0M | $897.0M |
| EBITDA (Normalized) | $1.19B | $949.7M | $1.18B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $628.0M | $1.27B | $1.30B |
| Capital Expenditures (CapEx) | $33.0M | $44.0M | $156.0M |
| Free Cash Flow (FCF) | $595.0M | $1.22B | $1.14B |
| FCF Margin % | 17.4% | 38.4% | 33.0% |
| Return on Invested Capital (ROIC %) | 2.8% | 2.2% | 22.5% |
| Cash & Short-Term Equivalents | $9.23B | $9.04B | $678.2M |
| Total Debt (Short + Long Term) | $33.63B | $32.87B | $1.44B |
| Total Stockholders' Equity | $8.85B | $8.82B | $2.96B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR FHN.